Pharmacokinetics of RO5072759 (GA101) In Patients with Relapsed/Refractory CD20+ Malignant Disease (Phase I/II Study BO20999)

被引：4
|
作者：
Meneses-Lorente, Georgina [1 ]
Carlile, David [1 ]
Birkett, Joe
Wenger, Michael K. [2 ]
Cartron, Guillaume [3 ]
Morschhauser, Franck [4 ]
Salles, Gilles Andre [5 ]
机构：
[1] Roche Prod Ltd, Clin Pharmacol, Welwyn Garden City AL7 3AY, Herts, England
[2] F Hoffmann La Roche Ltd, Basel, Switzerland
[3] Hop St Eloi, Serv Hematol Oncol Med, Montpellier, France
[4] Univ Hosp Lille, Lille, France
[5] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
10.1182/blood.V116.21.1833.1833
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：765 / 765
页数：1
相关论文
共 50 条
  • [31] Phase I study of DEC-C2B8 [rituximab] in patients with relapsed or refractory B-cell [CD20+] non-Hodgkin's lymphoma in Japan
    Ogura, M
    Morishima, Y
    Kobayashi, Y
    Sasaki, Y
    Ohtsu, T
    Murate, T
    Kinoshita, T
    Tobinai, K
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 407 - 407
  • [32] A phase I dose optimization study of anti-CD20 pretarget radioimmunotherapy in patients with relapsed or refractory NHL.
    Knox, SJ
    Forero-Torres, A
    Vose, JM
    Picozzi, VJ
    Breitz, H
    Sims, RB
    BLOOD, 2002, 100 (11) : 162A - 162A
  • [33] CC-122 IN COMBINATION WITH OBINUTUZUMAB (GA101): PHASE IB STUDY IN RELAPSED OR REFRACTORY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, FOLLICULAR LYMPHOMA, OR MARGINAL ZONE LYMPHOMA
    Michot, J. -M.
    Bouabdallah, R.
    Doorduijn, J. K.
    Vitolo, U.
    Kersten, M. J.
    Chiappella, A.
    Zinzani, P. L.
    Sarmiento, R.
    Mosulen, S.
    Petrarca, M.
    Pourdehnad, M.
    Hege, K.
    Yang, Z.
    Nikolova, Z.
    Ribrag, V.
    HAEMATOLOGICA, 2017, 102 : 172 - 173
  • [34] A phase I study of PRO131921, a novel anti-CD20 Monoclonal antibody in patients with relapsed/refractory CD20+indolent NHL: Correlation between clinical responses and AUC pharmacokinetics
    Casulo, Carla
    Vose, Julie M.
    Ho, William Y.
    Kahl, Brad
    Brunvand, Mark
    Goy, Andre
    Kasamon, Yvette
    Cheson, Bruce
    Friedberg, Jonathan W.
    CLINICAL IMMUNOLOGY, 2014, 154 (01) : 37 - 46
  • [35] Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20+ B-cell non-Hodgkin's lymphoma
    Witzig, TE
    White, CA
    Wiseman, GA
    Gordon, LI
    Emmanouilides, C
    Raubitschek, A
    Janakiraman, N
    Gutheil, J
    Schilder, RJ
    Spies, S
    Silverman, DHS
    Parker, E
    Grillo-López, AJ
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3793 - 3803
  • [36] A PHASE I/II CLINICAL STUDY TO INVESTIGATE EFFICACY, SAFETY AND PHARMACOKINETICS OF LENALIDOMIDE WITH/WITHOUT DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Iida, S.
    Nagai, H.
    Okamoto, S.
    Chou, T.
    Takatoku, M.
    Hotta, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 625 - 626
  • [37] Results from a phase I/II study of galiximab (anti-CD80) in combination with rituximab (anti-CD20) for relapsed or refractory, follicular NHL
    Leonard, J
    Friedberg, J
    Younes, A
    Fisher, D
    Gordon, L
    Moore, J
    Czuczman, M
    Miller, T
    Stiff, P
    Cheson, B
    Forero-Torres, A
    Nasizadeh, H
    Whiteley, M
    Leigh, BR
    ANNALS OF ONCOLOGY, 2005, 16 : 71 - 71
  • [38] Phase I/II study of the anti-CD30 antibody MDX-060 in patients with refractory/relapsed CD30 positive lymphoma
    Borchmann, P
    Ansell, S
    Byrd, J
    Horwitz, S
    Strair, R
    Khan, K
    Fischkoff, S
    Yellin, M
    Engert, A
    ANNALS OF ONCOLOGY, 2005, 16 : 71 - 72
  • [39] IDEC-114, an anti-CD80 monoclonal antibody for relapsed or refractory, follicular NHL: Phase I/II study of safety, efficacy, and pharmacokinetics.
    Czuczman, MS
    Witzig, TE
    Younes, A
    Moore, JO
    Vose, JM
    Miller, TP
    Grint, PC
    Leigh, BR
    BLOOD, 2002, 100 (11) : 163A - 163A
  • [40] Interim results of a phase I/II study of ocrelizumab, a new humanised Anti-CD20 antibody in patients with relapsed/refractory follicular non-hodgkin's lymphoma
    Morschhauser, Franck
    Marlton, Paula
    Vitolo, Umberto
    Linden, Ola
    Seymour, John
    Crump, Michael
    Coiffier, Bertrand
    Pulsoni, Alessandro
    Belch, Andrew
    Lerch, Erika
    Kimby, Eva
    Arnljots, Kristina
    Wassner, Elisabeth
    Mendila, Myriam
    BLOOD, 2007, 110 (11) : 199A - 199A
12345